BACKGROUND: Central neurocytomas (CN) are rare intraventricular tumors with benign clinical behavior that typically affect young adults. Although a favorable prognosis is generally expected after adequate management, there is no general consensus on the standard of therapy. We evaluated the efficacy and safety of radical surgery for the management of CN. METHODS: Between 1996 and 2010, 12 patients with CN (eight males and four females; range, 18 to 62 years; mean age, 28.5 years) were surgically treated in our institution. The initial goal of therapy was complete resection through a frontal transcortical approach, and repeat surgery was done in cases of residual or recurrent disease. The mean follow-up period was 51.2 months (range, 14-149 months). RESULTS: Complete resection was achieved in all patients either with primary (nine patients, 75 %) or second-look surgery (three patients, 25 %). No mortalities occurred and there were four surgery-related complications (two events of transient hemiparesis, one transient aphasia, and onepostoperative subdural hygroma). All patients were alive with normal activities of daily living at the last follow-up. Two patients (16.6 %) experienced a single recurrence at 26 and 66 months, one of whom underwent redo-surgery. CONCLUSION: For the management of CN, complete resection is feasible, effective, and safe. Repeat surgery may be a viable option in cases of residual or recurrent disease and the use of radiotherapy can be avoided in this young population.
BACKGROUND:Central neurocytomas (CN) are rare intraventricular tumors with benign clinical behavior that typically affect young adults. Although a favorable prognosis is generally expected after adequate management, there is no general consensus on the standard of therapy. We evaluated the efficacy and safety of radical surgery for the management of CN. METHODS: Between 1996 and 2010, 12 patients with CN (eight males and four females; range, 18 to 62 years; mean age, 28.5 years) were surgically treated in our institution. The initial goal of therapy was complete resection through a frontal transcortical approach, and repeat surgery was done in cases of residual or recurrent disease. The mean follow-up period was 51.2 months (range, 14-149 months). RESULTS: Complete resection was achieved in all patients either with primary (nine patients, 75 %) or second-look surgery (three patients, 25 %). No mortalities occurred and there were four surgery-related complications (two events of transient hemiparesis, one transient aphasia, and onepostoperative subdural hygroma). All patients were alive with normal activities of daily living at the last follow-up. Two patients (16.6 %) experienced a single recurrence at 26 and 66 months, one of whom underwent redo-surgery. CONCLUSION: For the management of CN, complete resection is feasible, effective, and safe. Repeat surgery may be a viable option in cases of residual or recurrent disease and the use of radiotherapy can be avoided in this young population.
Authors: Joonho Byun; Seok Ho Hong; Min Jae Yoon; Sae Min Kwon; Young Hyun Cho; Jeong Hoon Kim; Chang Jin Kim Journal: J Neurooncol Date: 2018-09-17 Impact factor: 4.130